TP53 and Li-Fraumeni syndrome: Germline CHEK2 variants were first described in patients without germline TP53 mutations who were thought to meet clinical criteria for Li-Fraumeni syndrome [7, 8], although the association with Li-Fraumeni syndrome has since been negated [9].